Laurence M. Corash - Mar 1, 2023 Form 4 Insider Report for CERUS CORP (CERS)

Role
Chief Scientific Officer
Signature
Laurence M. Corash by Chrystal Menard, attorney-in-fact
Stock symbol
CERS
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/3/2023, 04:14 PM
Previous filing
Mar 15, 2022
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERS Restricted Stock Unit Award $0 +110K +5.17% $0.00 2.24M Mar 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date.